Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Cervical cancer
Closed
Phase 3
This trial is looking at pembrolizumab for cervical cancer that has spread into the surrounding tissue (locally advanced) and has a high risk of coming back.
Recruitment start: 21 May 2021
Recruitment end: 18 November 2022
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Dr Susan Lalondrelle
Merck Sharp & Dohme Ltd
Last reviewed: 21 Nov 2022
CRUK internal database number: 17441
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
